Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / veridian-license-comparability-memo.docx
veridian-license-comparability-memo.docx
Parties
Harkness LLP
Genome Dx Therapeutics Inc
Georgia-Pacific Corp
Plywood Corp
Rite-Hite Corp
Kestrel Partners LLC
M. Factor
Ashworth Economics Group LLC
Dates
April 3, 2022
February 6, 2024
September 9, 2041
June 14, 2036
October 7, 2024
January 27, 2026
February 10, 2026
May 15, 2026
May 4, 2011
Amounts
$387.6
$32,088,000
$3,820
$5,775,840
$18,490,320
$4,210
$500,000
$3.33
$71.2
$32.1
Obligations
The analysis must be grounded in the facts of the case and must avoid the use of arbitrary benchmarks or rules of thumb
Two important limitations on the probative value of the Veridian license under this factor must be noted
The fact that the Veridian license was negotiated in a non-competitive context means that the 15% rate does not incorporate any competitive premium; the hypothetical Helios rate must include such a premium